SUMMARY The alkaline phosphatase-antialkaline phosphatase (APAAP) 
Myelodysplasia usually presents in elderly patients with a combination of peripheral blood cytopenias and dysplastic changes in both blood and bone marrow (for example, Pelger-Huet anomalies, dysmegakaryopoiesis). The natural history of myelodysplasia is variable: some patients enjoy a prolonged survival; in others the disease rapidly transforms into frank leukaemia within a year of diagnosis. '2 The unpredictable clinical behaviour of myelodysplasia prompted the FAB cooperative group to define criteria for classifying it into five categories: refractory anaemia (RA), refractory anaemia with ring sideroblasts (RAS), refractory anaemia with excess of blasts (RAEB), chronic myelomonocytic leukaemia (CMML), and RAEB in transformation (RAEB-t 
Circulating micromegakaryocytes in myelodysplasia micromegakaryocytes, superficially resembling lymphocytes, were detected in 16 of 17 (94%) marrow smears. These cells had small round nuclei and very scant and often ragged cytoplasm (fig 1c) .
In 23 of 67 (34%) peripheral blood samples from patients with myelodysplastic syndrome micromegakaryocytes positive for glycoprotein Illa were detected with both monoclonal antibodies (table). These cells were seen in smears of whole blood (five of 1351 19 cases or 26%) but could be detected more commonly (because of the higher concentration of nucleated cells) in buffy coat preparations (18 of 48 cases or 38%). The numbers of cells varied from patient to patient and even in buffy coat, smears did not exceed a few dozen per slide-that is, less than I % of nucleated cells.
The positive cells had a variety of morphological appearances (figs 2a-e). Most commonly they figs 2a and b) ; less commonly they were larger and had the appearance of blast cells (fig 2d) , or possessed large lobulated nuclei and lacked cytoplasm (fig 2e) .
When the FAB subtype of individual cases was analysed, it was found that circulating micromegakaryocytes were most commonly seen in RAEB and RAEB-t (table) .
Discussion
Circulating megakaryocytes were found in about one third of patients with myelodysplasia. These cells would usually be overlooked in routinely stained blood smears because of their low numbers and nondescript morphology. It was hence only by immunocytochemical labelling, using monoclonal antibodies to platelet glycoprotein IIIa, that these cells could be recognised. The necessity to use this type of technique to detect these cells is corroborated by the contrast between our own findings and the observation (based on conventional microscopy) of the FAB group that "rarely micromegakaryocytes can be recognised in the peripheral blood."3
The circulating cells positive for platelet glycoprotein seen in myelodysplasia are similar in morphology to the micromegakaryocytes we have previously detected (also by means of the APAAP staining technique) in the circulation of some cases of acute myeloblastic leukaemia4 and other myeloproliferative disorders (such as chronic granulocytic leukaemia and essential thrombocythemia; unpublished observations). The present study sheds light on the origin of the circulating micromegakaryocytes seen in patients with myelodysplasia as immunocytochemical labelling of bone marrow smears revealed, in addition to the previously described dysmegakaryopoietic features (such as multinucleated and abnormally large mononuclear megakaryocytes),3 8 many micromegakaryocytes.
In the present study circulating micromegakaryocytes were most commonly detected in cases of the RAEB and RAEB-t FAB subtypes of myelodysplastic syndrome (table) . It has previously been noted that these two diagnostic groups are most often associated with dysmegakaryopoietic features in the marrow9 and transformation to acute leukaemia.2 1 The "spill-over" of micromegakaryocytes from the marrow into the circulation in cases of RAEB and RAEB-t might possibly reflect the more aggressive nature of these forms of myelodysplasia.
In the other subgroups of myelodysplastic syndrome (RA, RAS, and CMML) circulating micromegakaryocytes were less commonly seen (table). It will be of interest to see whether the appearance of circulating micromegakaryocytes in these myelodysplastic syndrome subtypes with better prognosis' is of clinical importance-that is, heralds transition to more aggressive forms of myelodysplasia (RAEB or RAEB-t) or to acute leukaemia. If such a correlation is found regular immunocytochemical screening of peripheral blood samples for circulating micromegakaryocytes in patients with myelodysplastic syndrome would be warranted in their routine clinical management.
